v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue $ 6,567,000 $ 18,517,000
Cost of revenue 5,551,000 11,197,000
Gross profit (loss) 1,016,000 7,320,000
Operating expenses:    
Research and development 8,590,000 13,616,000
Selling, general and administrative 22,363,000 38,669,000
Restructuring costs 742,000
Total operating expenses 31,695,000 52,285,000
Loss from operations (30,679,000) (44,965,000)
Loss on debt restructuring (6,705,000)
Interest expense, net (4,354,000) (4,372,000)
Other income (expense), net (161,000) 13,000
Net loss from consolidated companies (41,899,000) (49,324,000)
Loss from minority interest in limited liability company (627,000) (657,000)
Comprehensive and net loss (42,526,000) (49,981,000)
Series B convertible preferred stock dividends (380,000)
Net loss attributable to common stockholders $ (42,906,000) $ (49,981,000)
Net loss per share of common stock:    
Basic and diluted (in dollars per share) $ (34.39) $ (160.92)
Weighted average shares used in computing net loss per common share:    
Weighted average shares (in shares) 1,247,768 310,589

Source